tiprankstipranks
Trending News
More News >

Christopher Martell Insider Profile

4 Followers
Christopher Martell, Director at Candel Therapeutics, holds 546.86K shares in Candel Therapeutics (Ticker: CADL).
tipranks
Christopher Martell

Christopher Martell
Candel Therapeutics (CADL)
Director

Ranked #90,333 out of 106,487 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-56.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Christopher Martell's holdings

Insider Roles

Candel Therapeutics
(CADL)
Director
Roles that Christopher Martell holds in companies

Most Profitable Insider Trade

Stock:
Candel Therapeutics
(CADL)
Rating:Informative Buy
Date:Aug 02, 2021 - Aug 02, 2022
Return:-56.00%
The most profitable trade made by Christopher Martell

Christopher Martell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Candel Therapeutics
Jun 26, 2025
Director
Uninformative Buy
520.00K
$2.72M
Success Rate for
CADL
0 out of 2 profitable transactions on
CADL
0%
Average Return for
CADL
Average return per transaction on
CADL
-56.10%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 02, 2021
Uninformative Buy
$0.00
283,514
$0.00
Aug 02, 2021
Informative Buy
$1.00M
125,000
$8.00
-56.00%
Dec 12, 2022
Informative Buy
$51.11K
27,000
$1.89
-56.20%
Jun 26, 2025
Uninformative Buy
$520.00K
111,349
$4.67
List of latest transactions for each holding click on a transaction to see Christopher Martell's performance on stock

Christopher Martell insider profile FAQ

What is the percentage of profitable transactions made by Christopher Martell?
The percentage of profitable transactions made by Christopher Martell is 0%.
    What is the average return per transaction made by Christopher Martell?
    The average return per transaction made by Christopher Martell is -56.10%.
      What stocks does Christopher Martell hold?
      Christopher Martell holds: CADL stocks.
        What was Christopher Martell’s latest transaction?
        Christopher Martell latest transaction was an Uninformative Buy of $520.00K.
          What was Christopher Martell's most profitable transaction?
          Christopher Martell’s most profitable transaction was an Informative Buy of CADL stock on August 2, 2021. The return on the trade was -56.00%.
            What is Christopher Martell's role in Candel Therapeutics?
            Christopher Martell's role in Candel Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.